Corrigendum: Table and Text Correction. Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians

Ahmed Iqbal; Peter Novodvorsky; Simon R. Heller

doi:10.4093/dmj.2018.42.2.177

Journal List > Diabetes Metab J > v.42(2) > 1142273

Go to TopGo to Top Go to BottomGo to Bottom

This corrects the article "Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians" on page 3.

TOOLS

Iqbal, Novodvorsky, and Heller: Corrigendum: Table and Text Correction. Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians

Corrigendum

Diabetes & Metabolism Journal 2018; 42(2): 177.

Published online: 19 April 2018

DOI: https://doi.org/10.4093/dmj.2018.42.2.177

Corrigendum: Table and Text Correction. Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians

Ahmed Iqbal^1,^2,^3,^*, Peter Novodvorsky^1,^2,^*, Simon R. Heller^1,²

¹Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

²Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

³Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

Equal contributor:

*Ahmed Iqbal and Peter Novodvorsky contributed equally to this study as first authors.

Korean Diabetes Association

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Diabetes Metab J 2018;42:3-18. https://doi.org/10.4093/dmj.2018.42.1.3

We have three errors in ‘Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians,’ these are as follows:

In Table 1, the manufacturer of insulin degludec (Tresiba) was wrongly listed as Sanofi. This should be NovoNordisk.
In the subsection ‘INSULIN PREPARATIONS AND ADMINISTRATION,’ on page 6, insulin degludec (Tresiba) was mentioned, but without manufacturer, this should be NovoNordisk.
In the subsection ‘USE OF METFORMIN IN T1DM,’ page 7, the original text ‘reduction of progression of caroT1DM artery intima-media thickness,’ should be corrected to ‘reduction of progression of carotid artery intima-media thickness.’

We apologize for any inconvenience that this may have caused.

TOOLS

ORCID iDs: Simon R. Heller
https://orcid.org/0000-0002-2425-9565
Similar articles